<DOC>
<DOCNO>
EP-0000644
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
C07C-69/738 C07C-69/732 C07C-233/13 C07C-275/24 C07C-41/00 A61K-31/357 C07C-57/00 A61K-31/12 C07C-33/50 C07C-43/168 C07C-215/38 C07D-213/00 C07C-45/00 C07C-59/00 C07C-233/31 C07C-59/56 C07C-57/48 C07C-217/48 C07C-233/05 C07C-233/18 C07C-29/00 C07C-233/87 C07C-229/36 C07C-29/14 C07C-215/00 C07C-229/00 C07C-217/00 C07C-59/72 C07C-311/00 C07C-69/157 C07C-67/00 C07C-275/00 C07C-301/00 C07C-45/59 C07C-49/252 C07C-229/34 C07C-309/00 C07C-43/00 C07C-41/26 C07C-311/03 C07D-317/30 C07C-233/47 C07D-213/80 C07D-317/00 C07C-227/00 C07C-69/734 A61K-31/445 C07C-29/147 C07C-311/04 A61K-31/19 C07C-49/00 C07C-309/73 C07D-295/00 C07C-233/00 A61K-31/185 C07D-295/145 C07C-43/178 C07C-69/00 A61K-31/335 C07C-33/00 A61K-31/21 A61P-29/00 C07C-27/00 
</IPC-CLASSIFICATIONS>
<TITLE>
lower cycloalkyl substituted-benzene derivatives, the preparation thereof and their pharmaceutical compositions
</TITLE>
<APPLICANT>
fujisawa pharmaceutical cojp<sep>fujisawa pharmaceutical co. ltd.<sep>fujisawa pharmaceutical co., ltd.3, doshomachi 4-chome higashi-kuosaka-shi osaka 541jp<sep>
</APPLICANT>
<INVENTOR>
kamiya takashijp<sep>shiokawa youichijp<sep>kamiya, takashi<sep>shiokawa, youichi<sep>kamiya, takashino. 1-11-16, furuedaisuitajp<sep>shiokawa, youichino. 18-502, tonda-danchi (kodan)no. 1319, makita-cho takatsuki(569)jp<sep>
</INVENTOR>
<ABSTRACT>
lower cycloalkyl substituted-benzene derivatives of the formula:-   <chem>  wherein r<1> is lower cycloalkyl, r<2> is carboxy, esterified carboxy, hydroxymethyl, lower alkoxymethyl or acyloxymethyl, r<3> is lower alkanoyl or lower alkyl substituted with hydroxy, amino, lower alkylamino, di(lower)alkylamino, acylamino, lower alkoxy, acyl or acyloxy, in which the lower alkyl moieties of the di(lower)alkyl amino radical may be joined together to form a heterocyclic ring containing the nitrogen atom and the carbonyl function of the acyl radical, which is a substituent on the lower alkyl radical, may be protected,  x is hydrogen or halogen, and y is a valency bond or lower alkylene; and pharmaceutically acceptable salts thereof; pharmaceutical composition comprising the same; and methods for treatment of inflammation by administering the same to mammals. 
</ABSTRACT>
</TEXT>
</DOC>
